Boston Scientific Goodwill accumulated impairment losses remained flat by 0.0% to $9.90B in Q3 2025 compared to the prior quarter. This is a positive signal — lower values indicate better performance for this metric.
High accumulated impairment losses suggest past overpayment for acquisitions or significant deterioration in the value of acquired business units.
This represents the cumulative amount of goodwill that has been written down due to impairment charges. It indicates his...
Investors look for low or zero impairment to confirm the quality of past M&A activity.
other_goodwill_impaired_accumulated_impairment_loss| Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|
| Value | $9.90B | $9.90B | $9.90B | $9.90B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% |